Cargando…
Gut, oral and nasal microbiota and Parkinson’s disease
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease, and in an effort to identify novel therapeutic target for this disease in recent years, human microbiota has attracted much interest. This paper briefly summarizes the main findings concerning the differences of human m...
Autor principal: | Shen, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045475/ https://www.ncbi.nlm.nih.gov/pubmed/32103766 http://dx.doi.org/10.1186/s12934-020-01313-4 |
Ejemplares similares
-
Approaching the Gut and Nasal Microbiota in Parkinson’s Disease in the Era of the Seed Amplification Assays
por: Consonni, Alessandra, et al.
Publicado: (2022) -
Parkinson’s Disease and the Gut: Symptoms, Nutrition, and Microbiota
por: Yemula, Nehal, et al.
Publicado: (2021) -
Gut Microbiota and Parkinson’s Disease: Implications for
Faecal Microbiota Transplantation Therapy
por: Kang, Yongbo, et al.
Publicado: (2021) -
New hope for Parkinson's disease treatment: Targeting gut microbiota
por: Fan, Hong‐Xia, et al.
Publicado: (2022) -
Gut microbiota: Implications in Parkinson's disease
por: Parashar, Arun, et al.
Publicado: (2017)